Literature DB >> 12960593

The radiation biology of radioimmunotherapy.

K L Dixon1.   

Abstract

The treatment of cancer is a wide and varied field, encompassing many methods and modalities. Radioimmunotherapy is a technique which utilizes the ablative properties of radiation by delivering radioactive particles directly to the tumour cells. This paper presents a summary of the research evidence that relates to the optimization of the effect of radioimmunotherapy. It includes discussion on the appropriate choice of radionuclide and monoclonal antibody; methods of increasing the radiation dose absorbed by the tumour; techniques available to increase the effect that the absorbed dose has on the tumour; and methods of protecting critical healthy tissue, particularly the bone marrow, from the effects of the radiation administered. 2003 Lippincott Williams & Wilkins

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960593     DOI: 10.1097/00006231-200309000-00002

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  4 in total

Review 1.  Radioimmunotherapy of non-Hodgkin's lymphoma: from the 'magic bullets' to 'radioactive magic bullets'.

Authors:  Murthy R Chamarthy; Scott C Williams; Renee M Moadel
Journal:  Yale J Biol Med       Date:  2011-12

Review 2.  Imaging virus-associated cancer.

Authors:  De-Xue Fu; Catherine A Foss; Sridhar Nimmagadda; Richard F Ambinder; Martin G Pomper
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

3.  Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.

Authors:  De-Xue Fu; Yvette Tanhehco; Jianmeng Chen; Catherine A Foss; James J Fox; Ja-Mun Chong; Robert F Hobbs; Masashi Fukayama; George Sgouros; Jeanne Kowalski; Martin G Pomper; Richard F Ambinder
Journal:  Nat Med       Date:  2008-09-07       Impact factor: 53.440

4.  Integrin targeted delivery of radiotherapeutics.

Authors:  Zhaofei Liu; Fan Wang; Xiaoyuan Chen
Journal:  Theranostics       Date:  2011-03-01       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.